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A B S T R A C T
The association between cigarette smoking and an increased risk of laryngeal carcinoma has been demonstrated in
numerous studies. The aim of the present study was to assess the prevalence of smoking habit in patients with different
laryngeal pathologies. The prevalence of cigarette smoking was compared between patients with laryngeal tumors and
those with nonmalignant laryngeal lesions. Data on all patients with indications for direct microlaryngoscopy at the
Clinic for Otorhinolaryngology of the University Hospital Center Split, during a five-year period were analyzed. The
study included 562 patients with various laryngeal pathologies, divided into three groups as follows: group 1, benign le-
sions; group 2, precancerous lesions; and group 3, tumors. The majority of patients (82.92%) had a long history of smok-
ing. The proportion of smokers was lowest in benign lesion group (72.13%), higher in precancerous lesion group
(81.48%) and highest in malignant lesion group (97.14%). There was a statistically significant difference in the preva-
lence of cigarette smoking between patients with laryngeal tumors and those with benign or precancerous lesions
(p<0.001). The mean number of cigarettes per day was 20.54±14.80, and was lowest in benign lesion group
(15.67±13.41) and highest in malignant lesion group (26.33±12.70). The mean length of smoking habit was 26.44±16.92
years, ranging from 19.57±16.03 years in benign lesion group to 35.20±12.12 years in malignant lesion group. Study re-
sults clearly pointed to the increased prevalence of laryngeal diseases in smokers, with a significant difference between
patients with benign laryngeal lesions and those with laryngeal tumors.
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Introduction
Cigarette smoking is a major factor of laryngeal car-
cinogenesis1–6. In smokers, the relative risk of laryngeal
tumor development is 5- to 30-fold risk recorded in non-
smokers4–9, increases with early onset of smoking habit
and depends on the length of smoking habit as well as as-
sociation with other risk factors. Maier et al. report
96.5% of patients with squamous cells carcinoma of the
larynx to be smokers, with a 5.6 relative risk of carci-
noma in smokers8. DeStefani et al. found 97.2% of smok-
ers and a relative risk of 14.72. Wunder et al. report on a
13.5 and 34.4 relative risk of tumor development in sub-
jects smoking up to 20 and more than 20 cigarettes daily,
respectively5. In the study by Falk et al., the relative risk
of squamous cell carcinoma was 6.0 in subjects smoking
up to 30 cigarettes and 19.2 in those smoking more than
30 cigarettes daily. The risk tended to decrease in former
smokers with at least 5-year history of nonsmoking, to
reach the level observed in nonsmokers after 15 years6.
Krajina found 97.6% of laryngeal tumor patients to smo-
ke 30 cigarettes daily on an average1.
In Croatia, 27.4% of the population over 18 years of
age smoke on a daily basis. The high prevalence of smok-
ing habit among young individuals aged 18–29 is a cause
for concern, with special reference to Eastern Croatia
where the prevalence rises to as high as 46%10. Statistical
data show a male predominance of smoking (34% male
vs. 22% of female). Surveys performed in Istria revealed
adolescents in Istria County to start smoking as early as
age 12–13 (32.09%); the habit of cigarette smoking was
more regularly practiced by female adolescents (35.72%)11.
Some 30% of the world population, 47% of men and
12% of women, are smokers. About 3.5 million individu-
als per year die from diseases caused by smoking in the
world. Cigarette smoking is the cause of death in 36% of
male and 13% of female individuals worldwide. In Croa-
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tia, 397 patients, 370 (93%) male and 27 (7%) female,
were newly diagnosed with laryngeal carcinoma in 200512.
The association between cigarette smoking and an in-
creased risk of laryngeal carcinoma has been definitely
demonstrated in numerous studies; however, tobacco
smoke causes laryngeal mucosa lesions, thus certainly fa-
voring the development of other laryngeal diseases as
well. Therefore, the aim of the present study was to as-
sess the prevalence of smoking habit in patients with dif-
ferent laryngeal pathologies. The prevalence of cigarette
smoking was compared between patients with laryngeal
tumors and those with nonmalignant laryngeal lesions.
Patients and Methods
Data on all patients (N=562) undergoing direct mi-
crolaryngoscopy at the Clinic for Otorhinolaryngology of
the University Hospital Center Split, over a five-year pe-
riod were collected and analyzed. Results were processed
by standard statistical methods.
Results
The study included 562 patients with different laryn-
geal pathologies, divided into three groups according to
histopathologic diagnosis as follows: 244 (43.4%) pa-
tients with benign laryngeal lesions (e.g., polyps, cysts,
hemangiomas, etc.) including patients with normal his-
topathology findings; 108 (19.2%) patients with precan-
cerous laryngeal lesions, including laryngeal papilloma;
and 210 (37.4%) patients with malignant lesions of the
larynx (Table 1).
Patient distribution according to gender and histo-
pathologic diagnosis is presented in Table 2. Whereas be-
nign lesion group showed an equal gender distribution,
male patients were predominant in group of patients
with precancerous lesion and malignant lesion (c2=34.8;
p<0.001). Overall, there were 408 (72.6%) male and 154
(27.4%) female patients.
Patient distribution according to age (age range 19–81;
mean age 53.53±14.21 years) is shown in Table 3. Dun-
can test following analysis of variance at the level of sig-
nificance revealed malignant lesion patients group to be
statistically significantly older than benign and precan-
cerous lesion patients group (F=15; p<0.001).
Most study patients (82.92%) had a long history of
cigarette smoking (Table 4). The proportion of smokers
was lowest in benign lesion group (72.13%) and highest
in malignant lesion group (97.14%). There was a statisti-
cally significant difference in the prevalence of smoking
habit between patients with laryngeal tumors and those
with benign or precancerous laryngeal lesions (c2=68.5;
p<0.001).
The mean number of cigarettes daily was 20.54±14.80;
it was lowest in benign lesion group (15.67±13.41 cigare-
ttes) and highest in malignant lesion group (26.33±12.70
D. Cikojevi} et al.: Smoking and Laryngeal Lesions, Coll. Antropol. 34 (2010) Suppl. 1: 45–48
46
TABLE 1
PATIENT DISTRIBUTION ACCORDING TO HISTOPATHOLOGIC DIAGNOSIS
Histopathologic diagnosis n (%) n (%)
Benign lesion group Benign 244 (43.4) 244 (43.4)
Precancerous lesion group Leukoplakia 40 (7.1) 108 (19.2)
Dysplasio gradus I 32 (5.7)
Dysplasio gradus II 20 (3.6)
Dysplasio gradus III 12 (2.1)
Papilloma 4 (0.7)




Squamous cell carcinoma 188 (33.6)
Total 562 (100) 562 (100)
TABLE 2
GENDER DISTRIBUTION OF STUDY PATIENTS
Histopathologic diagnosis
Gender Benign lesion group Precancerous lesion group Malignant lesion group Total
Male, n (%) 116 (20.6) 94 (16.7) 198 (35.3) 408 (72.6)
Female, n (%) 128 (22.8) 14 (2.5) 12 (2.1) 154 (27.4)
Total, N (%) 244 (43.4) 108 (19.2) 210 (37.4) 562 (100)
cigarettes). The mean length of smoking was 26.44±16.93
years; it was also shortest in benign lesion group
(19.57± 16.03 years) and longest in malignant lesion
group (35.20±12.12 years).
Discussion
In the group of patients with malignant laryngeal tu-
mors, the prevalence of cigarette smoking was 97.14%,
which is consistent with literature data. In Croatia, the
prevalence of smoking among women has increased in
recent years. The mean rate of smoking habit in women
worldwide is 12%, whereas in Croatia it reaches 22% or
even more in particular areas. In Istria County, 35.72% of
female high school students smoke regularly vs. 34.26%
of their male counterparts11. However, the marked in-
crease in the rate of cigarette smoking in female popula-
tion does not appear to be associated with an increased
prevalence of laryngeal tumors in this population group.
In the present study, a total of 12/210 (5%) malignant tu-
mors were diagnosed in female patients, out of which
only one was nonsmoker. Other factors (e.g., hormonal,
lower number of cigarettes daily, etc.) must also be in-
volved in carcinogenesis in women13.
In benign lesion group, there were 72.13% of smokers,
yielding a statistically significant difference from malig-
nant lesion group with 97.14% of smokers (c2=68.5;
p<0.001). Polls taken at the national level show the
mean rate of smoking habit in Croatia to be 27.4%; ac-
cordingly, the number of smokers in benign and malig-
nant lesion group was 2.6-fold and 3.5-fold mean rate re-
corded in Croatia.
Comparison of benign and malignant lesion group of
patients revealed the latter to be characterized by a sig-
nificantly older age (48.14 vs. 61.41 years), greater num-
ber of cigarettes daily (15.67 vs. 26.33 cigarettes), and
longer history of smoking (15.67 vs. 35.20 years).
A number of factors have been implicated in the in-
creased prevalence of laryngeal tumors in smokers. Some
fifty compounds with known carcinogenic effects have
been isolated from tobacco smoke. These mostly include
tar substances (e.g., polycyclic aromatic hydrocarbons),
and many other carcinogens such as toluidine, urethane,
polonium, naphthylamine, vinyl chloride, etc. One of the
adverse tobacco smoke compounds is carbon monoxide
(CO), which binds to hemoglobin 200 times faster than
oxygen. In smokers, 10% to 15% of hemoglobin can be
bound to CO, thus considerably reducing the body oxy-
gen supply, which may pose great risk in individuals with
heart diseases, angina pectoris in particular. In addition,
the vascular wall permeability for cholesterol increases,
thus favoring the atherosclerotic plaque formation.
It should also be noted that certain conditions addi-
tionally stimulate the action of these carcinogenic com-
pounds. A part of malignant tumors originate from a sin-
gle malignantly altered cell, so-called monoclonal malig-
nant cell, whereas others arise from precancerous le-
sions14,15. This is demonstrated by dysplastic changes of
variable grade frequently found along tumor margins.
Dysplastic changes always arise from the basal layer of
stratified squamous epithelial cells. Epithelial thickness
decreases with aging and the basal layer of stratified epi-
thelial cells is closer to the surface, thus being exposed to
the action of tobacco compounds. In young individuals,
epithelial thickness is about 50 microns, whereas in the
elderly it is only 29.9 microns16. In addition, in elderly in-
dividuals mitotic index is twofold that in children (1.72
vs. 0.88).
On the other hand, the area of stratified squamous
epithelium expands to the areas of stratified columnar
epithelium, which can be excellently visualized by con-
tact endoscopy17. Therefore, laryngeal tumors are rarely
found before age 30 and then are mostly associated with
irradiation therapy for laryngeal papilloma in childhood.
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TABLE 3
AGE DISTRIBUTION OF STUDY PATIENTS
Histopathologic diagnosis
Age (yrs) Benign lesion group Precancerous lesion group Malignant lesion group Total
X±SD 48.14±14.09 53.13±14.81 61.41±10.08 53.53±14.21
Total 122 (43.4%) 54 (19.2%) 105 (37.4%) 281 (100%)
TABLE 4
PATIENT DISTRIBUTION ACCORDING TO CIGARETTE SMOKING, NUMBER OF CIGARETTES PER DAY AND LENGTH OF SMOKING
HABIT
Histopathologic diagnosis
Beniagn lesion group Precancerous lesion group Malignant lesion group Total








Cigarettes per day, mean±SD 15.67±13.41 23.04±18.20 26.33±12.70 20.54±14.80
Length of smoking (yrs), mean±SD 19.57±16.03 28.70±19.61 35.20±12.12 26.44±16.93
The expansion of stratified squamous epithelium influ-
ences the mucociliary transport, thus slowing down the
elimination of nicotine compounds from the mucosal sur-
face while protracting and accumulating their action.
Conclusion
Study results pointed to the increased prevalence of
laryngeal diseases in smokers and a statistically signifi-
cant difference in the prevalence of smoking habit be-
tween patients with benign laryngeal lesions and those
with laryngeal tumor. The greater number of ciga-
rettes daily and longer history of smoking contributed
significantly to the increased prevalence of laryngeal
carcinoma.
Quitting smoking results in marked regression of the
initial pathologic lesions of the larynx, regeneration of
the stratified columnar epithelium and mucociliary tran-
sport, while frequent cough and throat dryness disap-
pear, strongly suggesting that stopping smoking is the
only favorable decision to make.
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PU[ENJE CIGARETA I LARINGEALNE PROMJENE
S A @ E T A K
Brojni radovi pokazuju jasnu vezu pu{enja i pove}anog rizika za nastanak tumora grla, ali duhanski dim o{te}enjem
sluznice larinksa zasigurno pogoduje nastanku i drugih oboljenja larinksa. Stoga smo u radu nastojali prikazali u~esta-
lost pu{enja u bolesnika s razli~itim oboljenjima larinksa. U radu smo analizirali sve bolesnike u kojih je bila indicirana
direktne mikrolaringoskopija na ORL odjelu KB Split u periodu od pet godina. Radom su obuhva}ena 562 bolesnika,
koje smo svrstali u tri grupe: grupa 1 – benigne promjene, grupa 2 – prekancerozne promjene, grupa 3 – tumori. Ve}ina
bolesnika su dugogodi{nji pu{a~i (82,92%). Najmanje pu{a~a bilo je u grupi 1 (72,13%), u grupi 2 (81,48%), a najvi{e u
grupi 3 (97,14%). Postoji statisti~ki zna~ajna razlika u u~estalosti pu{enja bolesnika s tumorom larinksa i bolesnika s
benignom ili prekanceroznom promjenom (c2=68,5, p<0,001). Dnevno su u prosjeku pu{ili 20,54±14,80 cigareta, naj-
manje u grupi 1 (15,67±13,41), a najvi{e u grupi 3 (26,33±12,70) cigareta. Bolesnici su prosje~no pu{ili 26,44±16,93
godine, najdu`e u grupi 3 (35,20±12,12) godina, a najkra}e u grupi 1 (19,57±16.03) godina. Prikazani rezultati jasno
ukazuju na pove}anu u~estalost oboljenja larinksa u pu{a~a, ali i zna~ajnu statisti~ku razliku o u~estalosti pu{enja u
bolesnika s benignim promjenama larinksa u odnosu na bolesnike s tumorom larinksa.
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